Skip to main content
SpringerLink
Log in

The introduction of a generic version of sanofi-aventis' Ambien [zolpidem] will enable “multi-million dollar savings”

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Medco Health Solutions Inc.New Analysis: Sleep Medication Use Surges, but Employers and Consumers Wake Up to Major Savings Opportunity with Generic Version of Blockbuster Insomnia Treatment. Media Release: 30 Apr 2007. Available from: URL: http://www.medco.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The introduction of a generic version of sanofi-aventis' Ambien [zolpidem] will enable “multi-million dollar savings”. Pharmacoecon. Outcomes News 528, 10 (2007). https://doi.org/10.2165/00151234-200705280-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705280-00026

Keywords

Search

Navigation